Abstract: Blepharocalyx salicifolius (Kunth) O. Berg, Myrtaceae, is an endemic species that occurs at Southern America. This species was studied to intend to isolation of the active compounds that could be used in vitro model against leishmaniosis, tumoral cell and paracoccidioidomycosis. After Gel Permeation Chromatography, the ethanolic extract from leaves yielded sixteen fractions. Five compounds were isolated and assayed, showing activity against tumoral cells, from 3.33 to 12.83 μg.mL -1 ; Leishmania (Leishmania) amazonensis from 2.19 to 20.80 μg.mL -1 and Paracoccidioides brasiliensis from 3.10 to 12.5 μg.mL -1 .
Introduction
Blepharocalyx salicifolius (Kunth) O. Berg, Myrtaceae, is an endemic species that occurs at Southern America, especially in countries like Brazil, Paraguay, Argentina and Uruguay. It is a bush that grows until 15 m length. The popular culture has presented several therapeutic indications for this species (Mors et al., 2000) . Biological activities, by means of infusion from leaves, have been described as antibacterial (with Staphylococcus aureus and Echerichia coli), anti-inflammatory, antinociceptive, antispasmodic and intestinal transit models (Limberger et al., 2001) . Five compounds were isolated and assayed against the pathogenic agents of the leishmaniasis, paracoccidioidomycosis and additionally against human cancer cell lines. It is necessary to improve the therapeutic arsenal against these diseases because the actual drugs are insufficient, very toxic or the parasites have presented resistance (Pecoul et al., 1999) . This work is part of the ongoing research project for this species, in order to discover compounds, from natural source, which can be used for this purpose. .
Material and Methods

General
Gel Permeation Chromatography (GPC) was carried out using Sephadex TM LH-20 gel (GE Healthcare, USA). Ethanol was used as mobile phase. Thin layer chromatography (TLC) was developed using silica HF 254 plates (Merck). The spots were visualized after spraying the plates with vanillin-sulfuric acid or NP/PEG (diphenylborinic acid ethanolamine ester -polyethylene glycol). Adsorptive column chromatography (ACC) was carried out using silica-gel 60-230 mesh (Merck) or Silicagel HF 60 (Merck). Reverse Phase HPLC (RP-HPLC) was carried out by Shimadzu HPLC System, using a Shimpack ® C18 column (5 μm, 250 mm x 20 mm i.d.). Gas Chromatography/Mass Spectrometry (GC/MS) analyses were performed on a Shimadzu QP-5050A instrument, equipped with a with a PTE™-5 column (30 m, 0.25 mm, 0.25 µm, Supelco, USA), using helium as the carrier gas. Nuclear Magnetic Resonance (NMR) experiments ( 1 H and 13 C, DEPT, HMQC, HMBC and COSY) were recorded on a Brucker DRX 400 spectrometer using standard Bruker pulse sequences and appropriate solvents. Electron impact (70 eV) low-resolution mass spectra (EI-MS) were obtained by means of direct injection on a Shimadzu QP5050A device.
Crude extract
Leaves of Blepharocalyx salicifolius (Kunth) O. Berg, Myrtaceae, species were collected at Parque Estadual do Rio Preto, Minas Gerais State, Brazil, in November 2006. Exsiccates of the species were committed at UFMG Herbarium (BHCB 87484). Crude extract was obtained by means of maceration of the B. salicifolius leaves. The material was dried using an oven at 35 ºC for two weeks. The leaves were grounded and conditioned in ethanol (analytical grade). Extraction process was performed three times. The raw extract was obtained after filtration and evaporation to dryness, using a rotary evaporator.
Isolation of the compounds
Raw extract (about 3.74 g) was dissolved in ethanol (20 mL) and injected in the GPC system. It was obtained 190 fractions that were grouped by means of TLC, according to chemical profile, using dichloromethane/methanol (95/5 v/v) as eluent and revealed with vanillin/sulfuric acid to give sixteen new fractions named F1 to F16.
The compounds 1 and 2 were obtained from F11 and F12 junction (373 mg) and dissolved in n-hexane (10 mL). It was subjected to ACC using a gradient, ranging from n-hexane (100%) to ethyl acetate (100%). The fractions were collected, yielding 1 (193 mg) and 2 (6.0 mg).
The compounds 3 (7 mg) and 4 (18 mg) were obtained from F16 fraction by means of preparative RP-HPLC methodology. The material from F16 fraction (150 mg) was dissolved in 10 mL methanol/water (1/1 v/v) and purified by RP-HPLC, using methanol/water gradient as eluent.
The F5 fraction (200 mg) was partitioned between methanol and n-hexane three times. The methanolic phase was partitioned sequentially, using a mixture of n-hexane/ethyl acetate (70/30 v/v), until complete exhaustion of methanolic phase. After evaporation of the solvent, this material was purified by ACC, using isocratic hexane/ethyl acetate (70/30 v/v) as eluent. The fractions were collected and analyzed by TLC, yielding compound 5 (17 mg). 193.4, 162.0, 159.4, 158.8, 142.9, 135.3, 130.2, 128.9, 128.4, 126.7, 109.0, 109.1, 106.7, 62.3, 8.2, 7.5 . MS/EI (M + ) 298. 194.1, 163.7, 161.7, 158.7, 143.4, 135.3, 130.4, 128.9, 128.5, 126.6, 115.7, 115.6, 111.9, 62.3, 60.1, 8.8, 8.7 . MS/EI (M + ) 312.
Compound 3 13 C NMR (100 MHz, CD 3 OD) δ 179. 8, 166.0, 163.4, 159.5, 158.7, 150.0, 146.6, 136.4, 123.1, 123.0, 117.1, 116.5, 103.7, 100.0, 94.8, 73.4, 72.3, 72.2, 72.0, 17.8 163.3, 159.5, 158.7, 150.0, 146.5, 135.1, 123.3, 123.2, 117.0, 116.6, 109.7, 100.0, 94.9, 88.2, 83.5, 78.9, 62.7 . MS/EI (M + ) 434. 138.3, 124.9, 78.3, 77.2, 55.1, 52.7, 47.4, 41.8, 39.2, 38.9, 38.7, 38.6, 38.5, 36.7, 36.7, 32.8, 30.6, 29.4, 28.0, 28.1, 27.0, 24.2, 23.3, 23.0, 21.0, 18.1, 16.8, 16.7, 15 .5, 15.1. MS/EI (M + ) 456.
Biological Assays
Cytotoxicity assays with human cancer cell lineages
The cytotoxicity assays were performed using the tumor cell lineages UACC-62 (human melanoma), MCF-7 (human breast cancer) and TK-10 (human renal cancer). The cell lineages were purchased from the National Cancer Institute (NCI, Maryland, USA). The cell toxicity assays were run according to the protocols established at NCI, using the sulphorhodamine colorimetric assay (Monks et al., 1991) . Results were expressed in terms of the growth inhibition percentage (%), where the sample tested was considered cytostatic 1996). The compound 2, (2E)-1-(4´-hydroxy-2´,6´-dimethoxy-3´,5´-dimethylphenyl)-3-phenylprop-2-en-1-one, showed similar structure to 1, seems to be an unedited substance. The compounds 3-4, isolated as pale yellow solids, were elucidated by means of NMR data, hydrolysis, peracetylation and GC/MS analysis (Cota et al., 2008; Monteiro et al.,2009; Monteiro et al., 2010) . It was possible to confirm the identity of the sugar moiety as rhamnose for 3 (Figure 1 ) and arabinose for 4 (Figure 2 ). Pure quercitrin, purchased from Sigma-Aldrich, has corroborated our elucidation for 3. This flavonoid is a usual substance, isolated from several species (Hallet & Parks 1951; Lopez, 1982; Kato et al., 2010) . The compound 4 had similar aglyconic molecular structure to 3 thus, the substance was elucidated as guaijaverin, a flavonoid found in several species (Mair et. al., 1987; Arisawa et al, 1993; Xu et al., 2009) . By means of spectroscopic data and literature (Seebacher et al, 2003; Silva et al, 2008) , it was possible to confirm the identity of the 5 as ursolic acid, (3β-hydroxy-urs-12-en-28-oic acid), an ursanic triterpene isolated from several species (Fu et al., 2005; Leite et al., 2006; Cunha et al., 2007) .
These five compounds are reported herein for the first time for this genus and species. Previous report about this genus has described GC-MS analysis of the essential oils, where the principal identified compounds were monoterpenes and sesquiterpenes (Limberger et al., 2001 ). 
Determination of the Minimal Inhibitory Concentrations (MIC)
Susceptibility was determined by the microbroth dilution method. Broth microdilution test was performed in accordance with the guidelines in the CLSI M27-A 2 document (NCCLS, 2002) and modifications suggested by Johann et al. (2010) .
Determination of the Minimal Fungicidal Concentrations (MFC)
The MFC values for pure compounds were determined according to Espinel-Ingroff et al. (2001) and Portillo et al. (2005) .
Results and Discussion
Isolated compounds
The structures of the compounds were established by their 1D and 2D NMR spectroscopic data and comparison with literature data. The compound 1 was identified as (2E)-1-(2´,4´-dihydroxy-6´-methoxy-3´,5´-dimethylphenyl)-3-phenylprop-2-en-1-one, a chalcone isolated in other species (Malterud et al., 1977; Gonzales et al., 1992; Gafner et al., isolates of P. brasiliensis, with MIC values ranging from 3.1 to 12.5 µg.mL -1 . The results for MFC activity for 1 were two concentration orders above MIC results for Pb-18 and Pb-B339 (3.1 and 12.5 μg.mL -1 , for both strains, respectively). Compound 2 demonstrated MFC results one concentration order above MIC for Pb-18, Pb-B339, Pb-01 and Pb-1578 strains (3.1 and 6.2 μg.mL -1 , for all strains, respectively). Although antifungal activity has been related to chalcones, this is the first work that describes fungicide activity for these compounds against P. brasiliensis. Chalcones 1 and 2 exhibited the best IC50 values against amastigoteslike of L. (L.) amazonensis between the five isolated compounds (5.23 and 2.19 μg.mL -1 , respectively). Torre- Santos et al. (1999) showed an IC50 of 24 μg.mL -1 against intracellular amastigotes of L. (L.) amazonensis for structurally similar chalcone, 2',6'-dihydroxy-4'-methoxychalcone, isolated from dichloromethane extract of Piper aduncum inflorescences.
Chalcones 1 and 2 were active against all cancer cell lineages tested. They presented values of IC50 ranging from 3.00 to 10.83 μg.mL -1 and MCF-7 lineage was the most sensitive to these compounds. The literature reports scarce biological activity for chalcone 1. It was noticed antimicrobial activity against Staphylococcus aureus (MIC of 250 µg.mL-1) (Belofsky et al., 2004) and Mycobacterium tuberculosis (MIC of 62.5 µg.mL -1 ) (Pavan et al., 2009 ) and it was not reported any biological activity for chalcone 2.
Quercitrin (3) and guaijaverin (4) exhibited only leishmanicidal activity, with IC50 values of 6.25 and 20.80 μg.mL -1 , respectively. The kind of sugar linked to aglycone moiety on flavonoids affects its activity. According to Muzitano et al. (2006) quercitrin, isolated from aqueous leaf´s extract from Kalanchoe pinnata, had an IC50 of 8 μg.mL -1 and the presence of quercetin aglycone and the sugars linked to, suggests the importance of this structural feature for antileishmanial activity. Aglycon quercetin, together with five of its glycosides, which includes quercitrin and guaijaverin, were isolated from Psidium guajava L. This species is used against diarrhea and the results demonstrated that the ability to inhibit peristalsis is mainly due to the aglycon quercetin (Lozoya et al., 1994) .
Ursolic acid is a ubiquitous pentacyclic triterpenoid in plant kingdom (Liu, 2005) . Our results demonstrated that this compound was had cytotoxic against all cell lineages tested (IC50 ranging from 10.83 to 12.83 μg.mL -1 ). This compound has showed (Takahashi et al., 2004) , respectively. In our results it demonstrated IC50 value of 9.34 μg.mL -1 against L. (L.) amazonensis.
Conclusions
It was isolated five compounds where the chalcone 2 seems be a new one. Although the other four compounds are usual, it was the first time that they were isolated in this genus and species. The chalcones 1 and 2 showed be active against all biological models researched moreover it was the first time that these compounds (1 and 2) were tested on these biological assays. Thus, these two chalcones are promising structures to the development of new drugs, showing the pharmacological potential of the Blepharocalyx salicifolius, a species little studied. 6.20/6.20 3.10/6.20 ≥200/≥200 ≥200/≥200 ≥200/≥200 300/300
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